Normal Growth of Nephrotic Children during Long‐term Alternate‐day Prednisone Therapy
- 1 March 1986
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 75 (2), 245-250
- https://doi.org/10.1111/j.1651-2227.1986.tb10193.x
Abstract
Statural growth has been evaluated in 20 prepubertal nephrotic children who received alternate‐day prednisone therapy for a year at least. Bone age was assessed in 16 of these children after 1‐4 years of therapy. During the follow‐up 12 children showed variations in height standard deviation score (SDs) below 0.5, 7 gained more than 0.5 SDs and 1 lost 0.5 SDs. Bone age fell within the normal range for chronological age in all the children studied. On the while alternate‐day prednisone therapy does not affect statural growth and bone maturation of children with lipoid nephrosis.Keywords
This publication has 7 references indexed in Scilit:
- THE EFFECT ON GROWTH OF CHILDHOOD ASTHMAActa Paediatrica, 1981
- Effect of Prednisone on Growth and Bone Mineral Content in Childhood Glomerular DiseaseArchives of Pediatrics & Adolescent Medicine, 1978
- Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosisKidney International, 1978
- Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.Archives of Disease in Childhood, 1976
- ADRENAL FUNCTION, GROWTH, AND INSULIN IN PATIENTS TREATED WITH CORTICOIDS ON ALTERNATE DAYSPediatrics, 1969
- Long-term dwarfing effects of corticosteroid treatment for childhood nephrosis.Archives of Disease in Childhood, 1968
- Effects of Prolonged Cortisone Therapy on the Statural Growth, Skeletal Maturation and Metabolic Status of ChildrenNew England Journal of Medicine, 1956